✦ LIBER ✦

Pharmacoeconomic analysis of advanced non-small cell lung cancer treatment with docetaxel-cisplatin, paclitaxel-cisplatin and paclitaxel-carboplatin

✍ Scribed by C. Rubio-Terrés; J.L. Tisaire; S. Kobina; A. Moyano

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN13: PHARMACOECONOMIC ANALYSIS OF ADVA

✍ C Rubio Terrés; JL Tisaire; S Kobina; A Moyano 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost-minimisation analysis of three regi

✍ Rubio-Terrés, Carlos; Luis Tisaire, Jose; Kobina, Svetlana; Moyano, Alfredo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Paclitaxel plus cisplatin in the treatme

✍ Tong Maorong; Cao Ehong; Xia Xirong; Shi Yi; Kang Xiaoming 📂 Article 📅 1996 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 149 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Cost-minimisation analysis comparing gem

✍ Novello, S.; Kielhorn, A.; Stynes, G.; Selvaggi, G.; De Marinis, F.; Maestri, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Cost-effectiveness of paclitaxel plus ci

✍ Earle, C C; Evans, W K 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB